Page last updated: 2024-08-26

uftoral and Experimental Mammary Neoplasms

uftoral has been researched along with Experimental Mammary Neoplasms in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hata, K; Hiraga, T; Ikeda, F; Tamura, D; Ueda, A; Williams, PJ; Yoneda, T	1
Kerbel, RS; Man, S; Munoz, R	1
Hosokawa, M; Kobayashi, M; Kuramitsu, Y; Li, YQ; Matsushita, K; Obara, M; Ohiro, Y	1

Reviews

1 review(s) available for uftoral and Experimental Mammary Neoplasms

Article	Year
On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testing. Cancer metastasis reviews, 2007, Volume: 26, Issue:3-4 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cyclophosphamide; Disease Models, Animal; Drug Combinations; Humans; Mammary Neoplasms, Experimental; Mice; Mice, SCID; Neoplasm Metastasis; Neoplasm Transplantation; Tegafur; Transplantation, Heterologous; Uracil	2007

Article

Year

On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testing.

Cancer metastasis reviews, 2007, Volume: 26, Issue:3-4

Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cyclophosphamide; Disease Models, Animal; Drug Combinations; Humans; Mammary Neoplasms, Experimental; Mice; Mice, SCID; Neoplasm Metastasis; Neoplasm Transplantation; Tegafur; Transplantation, Heterologous; Uracil

2007

Other Studies

2 other study(ies) available for uftoral and Experimental Mammary Neoplasms

Article	Year
Effects of oral UFT combined with or without zoledronic acid on bone metastasis in the 4T1/luc mouse breast cancer. International journal of cancer, 2003, Oct-10, Volume: 106, Issue:6 Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Diphosphonates; Disease Models, Animal; Drug Combinations; Female; Fluorouracil; Imidazoles; Luciferases; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Osteoclasts; Tegafur; Uracil; Zoledronic Acid	2003
Combination therapy of active hexose correlated compound plus UFT significantly reduces the metastasis of rat mammary adenocarcinoma. Anti-cancer drugs, 1998, Volume: 9, Issue:4 Topics: Adenocarcinoma; Animals; Basidiomycota; Cell Survival; Drug Combinations; Female; Killer Cells, Natural; Macrophages, Peritoneal; Mammary Neoplasms, Experimental; Neoplasm Metastasis; Nitric Oxide; Polysaccharides; Rats; Rats, Inbred SHR; Spleen; T-Lymphocytes; Tegafur; Uracil	1998

Article

Year

Effects of oral UFT combined with or without zoledronic acid on bone metastasis in the 4T1/luc mouse breast cancer.

International journal of cancer, 2003, Oct-10, Volume: 106, Issue:6

Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Diphosphonates; Disease Models, Animal; Drug Combinations; Female; Fluorouracil; Imidazoles; Luciferases; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Osteoclasts; Tegafur; Uracil; Zoledronic Acid

2003

Combination therapy of active hexose correlated compound plus UFT significantly reduces the metastasis of rat mammary adenocarcinoma.

Anti-cancer drugs, 1998, Volume: 9, Issue:4

Topics: Adenocarcinoma; Animals; Basidiomycota; Cell Survival; Drug Combinations; Female; Killer Cells, Natural; Macrophages, Peritoneal; Mammary Neoplasms, Experimental; Neoplasm Metastasis; Nitric Oxide; Polysaccharides; Rats; Rats, Inbred SHR; Spleen; T-Lymphocytes; Tegafur; Uracil

1998